A Novel Strategy for In Vitro Selection of Peptide-Drug Conjugates
- 31 March 2003
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 10 (3) , 233-239
- https://doi.org/10.1016/s1074-5521(03)00047-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Allosteric binding sites on cell-surface receptors: novel targets for drug discoveryNature Reviews Drug Discovery, 2002
- Complementation of the Essential Peptidoglycan Transpeptidase Function of Penicillin-Binding Protein 2 (PBP2) by the Drug Resistance Protein PBP2A in Staphylococcus aureusJournal of Bacteriology, 2001
- Molecular basis of antibiotic resistance and β-lactamase inhibition by mechanism-based inactivators: perspectives and future directionsFEMS Microbiology Reviews, 2000
- Peptide Antagonists of the Human Estrogen ReceptorScience, 1999
- Penicillin-Binding Protein 2a from Methicillin-Resistant Staphylococcus aureus: Kinetic Characterization of Its Interactions with β-Lactams Using Electrospray Mass SpectrometryBiochemistry, 1999
- Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural CytokineScience, 1997
- Phage DisplayChemical Reviews, 1997
- Randomization of genes by PCR mutagenesis.Genome Research, 1992
- Site-directed mutagenesis of .beta.-lactamase leading to accumulation of a catalytic intermediateBiochemistry, 1991
- A novel genetic system to detect protein–protein interactionsNature, 1989